PTC Therapeutics Inc

NASDAQGS:PTCT

美国 / 医疗保健 / 生物技术

概况

股息

10年收入现金流贴现退出法

股票价格

54.24 USD

公允价值

35.87 USD

Metrics	Range	Conclusion
Discount Rate	8.8% - 7.8%	8.3%
Terminal Revenue Multiple	3.2x - 3.6x	3.4x
Fair Value	32.02$ - 40.00$	35.87$
Upside	-41.0% - -26.2%	-33.9%

9.1%

Revenue 10y CAGR

7.6%

10y Avg EBITDA Margin

Unlevered FCF 10y CAGR

10-Year DCF Model: Revenue Exit

股票价格

54.24 USD

公允价值

35.87 USD

看涨

-33.9%

Revenue and EBITDA

CapEx

Working Capital

D&A

Tax Rate

Discount Rate

Terminal Value


Select Revenue and EBITDA Forecast

(USD in millions)		Input Projections
Fiscal Years Ending	Dec-24	Dec-25	Dec-26	Dec-27	Dec-28	Dec-29	Dec-30	Dec-31	Dec-32	Dec-33	Dec-34

Revenue	807	771	872	988	1,339	1,550	1,733	1,773	1,833	1,871	1,924
% Growth	-14.0%	-4.5%	13.2%	13.3%	35.5%	15.7%	11.8%	2.3%	3.4%	2.1%	2.8%

EBITDA	-71	-72	-18	19	126	185	224	229	237	242	248
% of Revenue	-8.8%	-9.3%	-2.0%	1.9%	9.4%	11.9%	12.9%	12.9%	12.9%	12.9%	12.9%

支持的计算方式

Calculation of Free Cash Flow

Discounting Periods

Discounting Factors

Calculation of Enterprise Value

Equity Waterfall

Historical Financials

Current Trading Multiples


Calculation of Free Cash Flow

Projected Unlevered Cash Flow
		Dec-25	Dec-26	Dec-27	Dec-28	Dec-29	Dec-30	Dec-31	Dec-32	Dec-33	Dec-34

EBITDA		(72)	(18)	19	126	185	224	229	237	242	248
Other Income / (Exp)		0	40	162	246	363	0	0	0	0	0
D&A		(28)	(32)	(36)	(49)	(57)	(64)	(65)	(68)	(69)	(71)

EBIT		(100)	(10)	145	323	490	160	163	169	173	177
Pro forma Taxes		0	0	(20)	(45)	(69)	(22)	(23)	(24)	(24)	(25)
NOPAT	(126)	(100)	(10)	125	277	422	137	141	145	148	153

Capital Expenditures	(7)	(13)	(20)	(25)	(38)	(42)	(35)	(36)	(37)	(36)	(36)
NWC Investment	(11)	(3)	9	10	31	18	16	4	5	3	5
(+) D&A	76	28	32	36	49	57	64	65	68	69	71

Free Cash Flow	(68)	(88)	11	146	320	455	182	174	181	185	192
% Growth			NM	1198%	119%	42%	-60%	-5%	4%	2%	4%

加载出错

PTC Therapeutics Inc

NASDAQGS:PTCT

美国 / 医疗保健 / 生物技术

10年收入现金流贴现退出法